Pharmacology in Rehabilitation, 3rd ed.Ciccone CD. Philadelphia, PA 19103, FA Davis Co, 2002, hardcover, 701 pp, illus, ISBN ISBN abbr. International Standard Book Number ISBN International Standard Book Number ISBN n abbr (= International Standard Book Number) → ISBN m : 0-8036-0779-2, $54.95. Unlike many pharmacology textbooks, this book was written specifically for rehabilitation professionals and primarily for physical therapists. The author is a physical therapist with expertise in pharmacology, which lends a unique professional perspective to this textbook. Case examples relevant to physical therapists are inserted at the end of every chapter, providing the reader with specific insights on how the drug class discussed in the chapter can interact with a therapy regimen. The cases also provide an opportunity for readers to reflect on their experiences with patients who are receiving a particular drug therapy. The author uses a generous number of tables, charts, and diagrams to help organize and explain drug-related concepts. This book consists of 37 chapters, which are organized into 8 sections. Most of these sections have been updated since the second edition of this book. The first section covers general principles of pharmacology and discusses the pharmacodynamics pharmacodynamics /phar·ma·co·dy·nam·ics/ (-di-nam´iks) the study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of their actions and effects with their chemical and pharmacokinetics involved in drug therapy. These chapters review drug administration, absorption, distribution, and elimination as well as drug receptor theory. This information lays the foundation for the remaining sections, which deal with the various drug classes. Each chapter has subsections that describe the various drugs or substances that fall into that class. The author also discusses the rationale for drug treatment for a particular disorder, the selection of specific agents to manage the disorder, the problems and adverse effects associated with a particular drug class, the mechanism of action, and, finally, special considerations and concerns for patients in rehabilitation. Section 2 describes central nervous system pharmacology and begins with a brief description of the various brain structures most likely involved in drug interactions. This is followed by an explanation of the different neurotransmitters involved in drug-receptor interactions. The author includes sedative-hypnotic, antianxiety antianxiety /an·ti·an·xi·e·ty/ (-ang-zi´e-te) anxiolytic; reducing anxiety. an·ti·anx·i·e·ty adj. Preventing or reducing anxiety. , antipsychotic, antiepileptic, antiparkinsonian, and anesthetic (local and general) drugs in this group. Whenever a drug class is discussed within the context of a disease such as Parkinson disease, the author provides a concise overview of the disease, making the relationship between drug and target tissue clear. Section 3 covers drugs that affect skeletal muscle relaxation in the treatment of spasticity. Drugs such as baclofen, dantrolene sodium, and gabapentin are included, along with newer additions such as tizanidine and botulinum toxin. Section 4 describes drugs used to treat pain and inflammation, including the opioid analgesics, nonsteroidal antiinflammatory drugs, patient-controlled analgesia (PCA (tool, programming) PCA - A dynamic analyser from DEC giving information on run-time performance and code use. ), and drugs used in the pharmacological management of both rheumatoid arthritis and osteoarthritis. Section 5 covers autonomic and cardiovascular pharmacology. The anatomy and physiology of the autonomic nervous system autonomic nervous system: see nervous system. autonomic nervous system Part of the nervous system that is not under conscious control and that regulates the internal organs. It includes the sympathetic, parasympathetic, and enteric nervous systems. are explained as a lead-in to a more in-depth discussion of adrenergic adrenergic /ad·ren·er·gic/ (ad?ren-er´jik) 1. activated by, characteristic of, or secreting epinephrine or related substances, particularly the sympathetic nerve fibers that liberate norepinephrine at a synapse when a nerve , cholinergic cholinergic /cho·lin·er·gic/ (ko?lin-er´jik) 1. parasympathomimetic; stimulated, activated, or transmitted by choline (acetylcholine); said of the sympathetic and parasympathetic nerve fibers that liberate acetylcholine at a , and antihypertensive drugs. The author also discusses drugs used in the management of angina, arrhythmias, and congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. and the treatment of coagulation disorders. Section 6 explains respiratory and gastrointestinal pharmacology. Specific drugs include the antitussives, decongestants Decongestants Definition Decongestants are medicines used to relieve nasal congestion (stuffy nose). Purpose A congested or stuffy nose is a common symptom of colds and allergies. , antihistamines Antihistamines Definition Antihistamines are drugs that block the action of histamine (a compound released in allergic inflammatory reactions) at the H1 , and expectorants Expectorants Definition Expectorants are drugs that loosen and clear mucus and phlegm from the respiratory tract. Purpose The drug described here, guaifenesin, is a common ingredient in cough medicines. . Ciccone describes the pathophysiology of the conditions, including cystic fibrosis and asthma, managed by these drugs. The gastrointestinal compounds described include the [H.sub.2]-receptor blockers and proton pump inhibitors Proton Pump Inhibitors Definition The proton pump inhibitors are a group of drugs that reduce the secretion of gastric (stomach) acid. They act by binding with the enzyme H+, K(+)-ATPase, hydrogen/potassium adenosine triphosphatase . The author makes a concerted effort to subtly update the reader on new findings that may be relevant in the treatment of a disorder. For example, he describes the bacterial nature (H pylori) underlying gastric ulcer disease and the rationale for the use of antibiotics in the management of this condition. Section 7 covers endocrine pharmacology and begins with an explanation of the endocrine organs and hormones that each produces. After reviewing endocrine physiology and pharmacology, the author embarks on a description of several hormone groups including the adrenocorticosteroids, male and female hormones, thyroid/ parathyroid hormones, and pancreatic hormones. The chapter dealing with diabetes mellitus provides a comprehensive pharmacological overview and also includes a section on nonpharmacological intervention. Section 8 is the final section of the book and contains several chapters that discuss chemotherapy and neoplastic neoplastic /neo·plas·tic/ (ne?o-plas´tik) 1. pertaining to a neoplasm. 2. pertaining to neoplasia. neoplastic pertaining to neoplasia or a neoplasm. diseases. This section includes a discussion of antibacterial, antiviral, antifungal, antiparasitic antiparasitic /an·ti·par·a·sit·ic/ (-par?ah-sit´ik) destructive to parasites, or an agent with this quality. an·ti·par·a·sit·ic adj. , chemotherapeutic, and immunomodulating agents. The back of the book has 5 appendixes that are useful adjuncts to the main text. The appendixes include a list of drugs and compounds used in phonophoresis and iontophoresis iontophoresis /ion·to·pho·re·sis/ (i-on?to-fah-re´sis) the introduction of ions of soluble salts into the body by means of electric current.iontophoret´ic i·on·to·pho·re·sis n. , a chart describing interactions between physical agents and certain drugs, a demonstration of how to use the Physician's Desk Reference Physician's Desk Reference (PDR), n an informational, scientifically validated resource that provides information relating to indications, chemical formulations, actions and potential hazards associated with most medicinal remedies currently being used. , a list of the drugs with high abuse potential, and a list of the common drug suffixes that will make drug recognition easier. The book also has an extensive glossary and index. This book contains a great amount of information that has immediate relevance in any physical therapy setting where patients are taking medications. In a rapidly changing field such as pharmacology, the author has managed to condense much research information into a concise and very user-friendly format. This textbook was written primarily for rehabilitation professionals, and the case examples at the end of each chapter provide practical scenarios that readers can use as problem-solving exercises. This book is a thorough, well-referenced text that any rehabilitation professional will appreciate. The theme--pharmacology in rehabilitation--is universal because it transcends all our specialties. I recommend this text to both beginning and expert clinicians who want a more comprehensive understanding of pharmacology in rehabilitation. Tiziano Marovino, PT Preferred Medicine Allen Park, Mich Mr Marovino is a doctoral student at Creighton University and a practice manager at a sports and outpatient orthopedic practice in Michigan. His research interests include biomechanics and exercise theory. Note: Author Charles Ciccone, PT, PhD, who is Editor for "Evidence in Practice" and Reviews, did not participate in the review process for this book, including reviewer assignment and editing. |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion